Quarterly report pursuant to Section 13 or 15(d)

Insider Trading Arrangements

v3.24.3
Insider Trading Arrangements - Shalabh Gupta [Member]
 3 Months Ended
Sep. 30, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During the three months ended September 30, 2024, no Section 16 officers and directors adopted, modified or terminated a “Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchange Act), except that on September 20, 2024, Shalabh Gupta, M.D., our Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 900,000 shares of our common stock beginning on January 20, 2025 and terminating on January 19, 2026.
Name Shalabh Gupta
Title M.D., our Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Non-Rule 10b5-1 Arrangement Adopted false
Adoption Date September 20, 2024
Rule 10b5-1 Arrangement Terminated true
Non-Rule 10b5-1 Arrangement Terminated false
Termination Date January 19, 2026
Aggregate Available 900,000
Rule 10b5-1 Arrangement Modified [Flag] false
Non-Rule 10b5-1 Arrangement Modified [Flag] false